📣 VC round data is live. Check it out!
- Public Comps
- Sugi Holdings
Sugi Holdings Valuation Multiples
Discover revenue and EBITDA valuation multiples for Sugi Holdings and similar public comparables like Nahdi Medical, Clicks Group, Jointown Pharmaceutical, DaShenLin Pharmaceutical and more.
Sugi Holdings Overview
About Sugi Holdings
Sugi Holdings Co Ltd is a Japan-based company engaged in drugstore operations and the pharmaceutical dispensing business. Through its subsidiaries, the company is involved in selling pharmaceuticals, health foods, cosmetics, daily essentials, and prescription drugs. It also operates community-based drugstores that support home healthcare in collaboration with local medical professionals. The company also supports regional healthcare facilities and provides at-home nursing services.
Founded
1982
HQ

Employees
25.9K
Website
Sectors
Financials (LTM)
EV
$3B
Valuation Multiples
Start free trialSugi Holdings Financials
Sugi Holdings reported last 12-month revenue of $6B and EBITDA of $441M.
In the same LTM period, Sugi Holdings generated $2B in gross profit, $441M in EBITDA, and $271M in net income.
Revenue (LTM)
Sugi Holdings P&L
In the most recent fiscal year, Sugi Holdings reported revenue of $6B and EBITDA of $358M.
Sugi Holdings is profitable as of last fiscal year, with gross margin of 31%, EBITDA margin of 6%, and net margin of 3%.
Financial data powered by Morningstar, Inc.
Sugi Holdings Stock Performance
Sugi Holdings has current market cap of $4B, and enterprise value of $3B.
Market Cap Evolution
Sugi Holdings' stock price is $19.84.
Sugi Holdings share price increased by 1.5% in the last 30 days, and decreased by 0.5% in the last year.
Sugi Holdings has an EPS (earnings per share) of $0.90.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $4B | -0.1% | 1.5% | -12.2% | -0.5% | $0.90 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSugi Holdings Valuation Multiples
Sugi Holdings trades at 0.5x EV/Revenue multiple, and 7.9x EV/EBITDA.
EV / Revenue (LTM)
Sugi Holdings Financial Valuation Multiples
As of May 3, 2026, Sugi Holdings has market cap of $4B and EV of $3B.
Sugi Holdings has a P/E ratio of 13.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Sugi Holdings Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Sugi Holdings Margins & Growth Rates
Sugi Holdings grew revenue by 14% and EBITDA by 21% in the last fiscal year.
In the most recent fiscal year, Sugi Holdings reported gross margin of 31%, EBITDA margin of 6%, and net margin of 3%.
Sugi Holdings Margins
Sugi Holdings Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Sugi Holdings Operational KPIs
Sugi Holdings' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Sugi Holdings' Rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Sugi Holdings' Rule of X is 31% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Sugi Holdings Competitors
Sugi Holdings competitors include Nahdi Medical, Clicks Group, Jointown Pharmaceutical, DaShenLin Pharmaceutical, COSMOS Pharmaceutical, Yifeng Pharmacy, CR Pharmaceutical, Sundrug, Fragua and Ebos Group.
Most Sugi Holdings public comparables operate across Pharmacies.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.5x | 1.4x | 8.6x | 8.5x | |||
| 1.3x | 1.2x | 9.3x | 9.0x | |||
| 0.2x | 0.2x | 5.3x | 5.7x | |||
| 0.7x | 0.7x | 5.4x | 5.5x | |||
| 0.5x | 0.5x | 7.7x | 7.7x | |||
| 0.9x | 0.9x | 5.3x | 7.3x | |||
| 0.3x | 0.3x | 4.1x | 4.3x | |||
| 0.5x | 0.5x | 6.3x | 6.3x | |||
This data is available for Pro users. Sign up to see all Sugi Holdings competitors and their valuation data. Start Free Trial | ||||||
Sugi Holdings Investment Activity
Sugi Holdings has invested in 2 companies to date.
Latest investment by Sugi Holdings was on January 12th 2020. Sugi Holdings invested in WonderFull (Wandou Gongzhu) in their $49M Series B round (EV/Revenue multiple of ).
Latest Investments by Sugi Holdings
| Description | WonderFull, also known as Wandou Gongzhu, is a Beijing-based e-commerce platform specializing in authentic Japanese products including cosmetics, snacks, health supplements, and household goods. It sources directly from Japanese suppliers and offers services like cross-border shipping, quality verification, and customer support in Mandarin for mainland Chinese consumers seeking premium imports. | Inagora is a cross-border e-commerce operator running Wandou, a Chinese-language platform dedicated to Japanese cosmetics, apparel, and food brands. The Tokyo-headquartered company curates around 40,000 products for millions of users in China, leveraging logistics partnerships for direct-from-Japan shipping. Strategic investments from Itochu Corporation bolster its supply chain and marketing efforts, positioning Wandou as a key channel for premium imports amid rising demand for authentic overseas goods. |
| HQ Country | ||
| HQ City | Beijing | Tokyo |
| Deal Date | 12 Jan 2020 | 10 Jan 2020 |
| Round | Series B | Strategic investment |
| Raised | $49M | $49M |
| Investors | SBI Holdings; Sugi Holdings; Xinjing Holding | SBI Holdings; Sugi Holdings; XJ Holding |
| Valuation | undisclosed | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Sugi Holdings investments and their VC round multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Sugi Holdings
| When was Sugi Holdings founded? | Sugi Holdings was founded in 1982. |
| Where is Sugi Holdings headquartered? | Sugi Holdings is headquartered in Japan. |
| How many employees does Sugi Holdings have? | As of today, Sugi Holdings has over 25K employees. |
| Is Sugi Holdings publicly listed? | Yes, Sugi Holdings is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Sugi Holdings? | Sugi Holdings trades under 7649 ticker. |
| When did Sugi Holdings go public? | Sugi Holdings went public in 2001. |
| Who are competitors of Sugi Holdings? | Sugi Holdings main competitors include Nahdi Medical, Clicks Group, Jointown Pharmaceutical, DaShenLin Pharmaceutical, COSMOS Pharmaceutical, Yifeng Pharmacy, CR Pharmaceutical, Sundrug, Fragua, Ebos Group. |
| What is the current market cap of Sugi Holdings? | Sugi Holdings' current market cap is $4B. |
| What is the current revenue of Sugi Holdings? | Sugi Holdings' last 12 months revenue is $6B. |
| What is the current revenue growth of Sugi Holdings? | Sugi Holdings revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Sugi Holdings? | Current revenue multiple of Sugi Holdings is 0.5x. |
| Is Sugi Holdings profitable? | Yes, Sugi Holdings is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Sugi Holdings? | Sugi Holdings' last 12 months EBITDA is $441M. |
| What is Sugi Holdings' EBITDA margin? | Sugi Holdings' last 12 months EBITDA margin is 7%. |
| What is the current EV/EBITDA multiple of Sugi Holdings? | Current EBITDA multiple of Sugi Holdings is 7.9x. |
| What is the current FCF of Sugi Holdings? | Sugi Holdings' last 12 months FCF is $121M. |
| What is Sugi Holdings' FCF margin? | Sugi Holdings' last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of Sugi Holdings? | Current FCF multiple of Sugi Holdings is 28.7x. |
| How many companies Sugi Holdings has acquired to date? | Sugi Holdings hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Sugi Holdings has invested to date? | As of May 2026, Sugi Holdings has invested in 2 companies. |
| What was the last Sugi Holdings investment? | On 12th January 2020 Sugi Holdings invested in WonderFull (Wandou Gongzhu), participating in a $49M Series B round, alongside SBI Holdings and Xinjing Holding. |
| In what companies Sugi Holdings invested in? | Sugi Holdings invested in WonderFull (Wandou Gongzhu) and Inagora. |
See public comps similar to Sugi Holdings
Lists including Sugi Holdings
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

